普里米酮
医学
拉莫三嗪
奥卡西平
卡马西平
托吡酯
唑尼沙胺
左乙拉西坦
癫痫
拉考沙胺
氯硝西泮
加巴喷丁
苯妥英钠
维加巴丁
硫加宾
骨质疏松症
药理学
苯巴比妥
儿科
内科学
抗惊厥药
精神科
替代医学
病理
作者
Barbara Miziak,Barbara Błaszczyk,Magdalena Chrościńska–Krawczyk,Grzegorz Danilkiewicz,E Jagiełło-Wójtowicz,Stanisław Jerzy Czuczwar
标识
DOI:10.1517/14740338.2014.919255
摘要
INTRODUCTION: Epilepsy is a common neurological disorder associated with recurrent seizures. Therapy with antiepileptic drugs (AEDs) helps achieve seizure remission in approximately 70% of epileptic patients. Treatment with AEDs is frequently lifelong and there are reports suggesting its negative influence on bone health. This is especially important in terms of general occurrence of osteoporosis, affecting over 50 million people worldwide. AREAS COVERED: This study refers to two main groups of AEDs: hepatic enzyme inducers (carbamazepine, oxcarbazepine, phenobarbital, phenytoin, primidone and topiramate) and non-inducers (clobazam, clonazepam, ethosuximide, gabapentin, lacosamide, lamotrigine, levetiracetam, pregabalin, tiagabine, valproate, vigabatrin and zonisamide). Some reports indicate that enzyme inducers may exert a more negative influence on bone mineral density (BMD) compared to non-inducers. Bone problems may appear in both sexes during AED therapy, although women are additionally burdened with postmenopausal osteoporosis. Supplementation of vitamin D and calcium in patients on AEDs is recommended. EXPERT OPINION: Apart from enzyme inducers, valproate (an even enzyme inhibitor) may also negatively affect BMD. However, the untoward effects of AEDs may depend upon their doses and duration of treatment. Although the problem of supplementation of vitamin D and calcium in epileptic patients on AEDs is controversial, there are recommendations to do so.
科研通智能强力驱动
Strongly Powered by AbleSci AI